Ikuo Hirano, MD, the chair of the writing committee, answers our questions about the new ACG/JTF guidelines on the management of eosinophilic esophagitis.
4 Questions About Endoscopic Submucosal Dissection in Barrett Esophagus–Related Superficial Neoplasia
Lady Katherine Mejia Perez, MD, from the Cleveland Clinic, answers our questions about her research on endoscopic submucosal dissection and endoscopic mucosal resection for the treatment of patients with Barrett esophagus–related superficial neoplasia.
Ikuo Hirano, MD, from the Northwestern University Feinberg School of Medicine, answers our questions about his research presentation on the safety and efficacy of budesonide oral suspension for the treatment of adolescents and adults with eosinophilic esophagitis.
Scott Simpson, MD, answers our questions about his research on whether reflux scintigraphy is clinically useful in the diagnosis of laryngopharyngeal reflux (LPR) and can aid in optimizing treatment of patients with LPR.
Jonathan Spergel, MD, PhD, on Epicutaneous Immunotherapy for Pediatric Milk-Induced Eosinophilic Esophagitis
Dr Spergel discusses the current management of milk-induced eosinophilic esophagitis among children and his study that evaluated epicutaneous immunotherapy as a potential treatment option.
Dr Sangeeta Agrawal, the Division Director of Gastroenterology at Wright State University discusses her recently published systematic review on MicroRNA and the progression of Barrett esophagus.
In this podcast, Dr Knotts, Section Editor for Esophageal Diseases and Disorders on Gastroenterology Learning Network, discusses the risk factors for Barrett esophagus, how it relates to the risk of esophageal cancer, who should be screened, and the screening methods available.